BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37144952)

  • 1. Opportunities to address gaps in early detection and improve outcomes of liver cancer.
    McMahon B; Cohen C; Brown RS; El-Serag H; Ioannou GN; Lok AS; Roberts LR; Singal AG; Block T
    JNCI Cancer Spectr; 2023 May; 7(3):. PubMed ID: 37144952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.
    McMahon B; Block J; Block T; Cohen C; Evans AA; Hosangadi A; London WT; Sherman M;
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26626106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of hepatocellular carcinoma: roadmap for improvement.
    Melendez-Torres J; Singal AG
    Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and early detection biomarkers for precision HCC screening.
    Lee YT; Fujiwara N; Yang JD; Hoshida Y
    Hepatology; 2023 Jul; 78(1):319-362. PubMed ID: 36082510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
    Hanouneh IA; Alkhouri N; Singal AG
    Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review.
    Beal EW; Owen M; McNamara M; McAlearney AS; Tsung A
    J Gastrointest Cancer; 2023 Jun; 54(2):332-356. PubMed ID: 35879510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach.
    Koo E; Singal AG
    Surg Oncol Clin N Am; 2024 Jan; 33(1):13-28. PubMed ID: 37945138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
    Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
    Schauer C; Mules T; Rijnsoever MV; Gane E
    N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
    Zhao C; Nguyen MH
    J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for hepatocellular carcinoma.
    Della Corte C; Colombo M
    Semin Oncol; 2012 Aug; 39(4):384-98. PubMed ID: 22846857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
    Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
    Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Promoting thorough action for early screening, diagnosis and treatment of liver cancer].
    Fan R; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):817-821. PubMed ID: 31941233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
    BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: Available modalities for screening and imaging diagnosis of hepatocellular carcinoma-Current gaps and challenges.
    Barnard Giustini A; Ioannou GN; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2023 May; 57(10):1056-1065. PubMed ID: 37038283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.